Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Kriege, M.; Hollestelle, A.; Jager, A.; Huijts, P.E.A.; Berns, E.M.; Sieuwerts, A.M.; ... ; Seynaeve, C. (2014)

Article / Letter to editor

• adjuvant chemotherapy
• breast cancer
• CHEK2 1100delC
• contralateral breast cancer
• survival

• All authors: Kriege, M.; Hollestelle, A.; Jager, A.; Huijts, P.E.A.; Berns, E.M.; Sieuwerts, A.M.; Meijer-van Gelder, M.E.; Collee, J.M.; Devilee, P.; Hooning, M.J.; Martens, J.W.M.; Seynaeve, C.
• Date: 2014-08-26
• Journal: British Journal of Cancer
• Volume: 111
• Issue: 5
• Pages: 1004 - 1013
• DOI: doi:10.1038/bjc.2014.306